MIZORIBINE TABLET WITH IMPROVED COLOR TONE CHANGE

Title:

MIZORIBINE TABLET WITH IMPROVED COLOR TONE CHANGE

Document Type and Number:

Japanese Patent JP2007269814

Kind Code:

A

Abstract:

To provide a more superior tablet containing mizoribine, fulfilling various requirements of a medical site having possibility of being required in the future.

The mizoribine tablet is constituted of a core body containing the mizoribine as an active ingredient, and a pharmaceutically acceptable film coating base covering the core body, and has ≤30 min disintegration time and improved color tone change in an unpackaged state.

More Like This:

WO/2012/107402	IDRABIOTAPARINUX FOR THE TREATMENT OF PULMONARY EMBOLISM AND FOR THE SECONDARY PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS
WO/2022/136307	NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
JP2022521996	Treatment of TNFα-related diseases

Inventors:

SUZUKI KAZUMI
SUMITA YUKIO

Application Number:

JP2007162131A

Publication Date:

October 18, 2007

Filing Date:

June 20, 2007

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ASAHI KASEI PHARMA KK

International Classes:

A61K31/7056; A61K9/30; A61K47/32; A61K47/38; A61P13/12; A61P29/00; A61P37/06

Domestic Patent References:

JPS57156418A	1982-09-27
JPH03157393A	1991-07-05
JP4046475B

Attorney, Agent or Firm:

Yoshio Kawaguchi
Makoto Ono
Chihiro Watanabe
Kenkyo Kanayama
Katsuma Osaki
Mitsuaki Tsubokura

Previous Patent: ANTISEPTIC STERILIZER, AND COMPOSITION FOR APPLICATION TO HUMAN BODY

Next Patent: STEROID AS AGONIST FOR FXR